804561-63-5

Basic information

• Product Name: 2',3'-di-O-tert-butyldimethylsilyl-5'-O-cis-[4-(R)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]cytosine-1-β-D-arabinofuranoside
• Synonyms: 2',3'-di-O-tert-butyldimethylsilyl-5'-O-cis-[4-(R)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]cytosine-1-β-D-arabinofuranoside
• CAS NO: 804561-63-5
• Molecular Weight: 702.332
• Mol File: 804561-63-5.mol

Chemical Properties

• CAS DataBase Reference: 2',3'-di-O-tert-butyldimethylsilyl-5'-O-cis-[4-(R)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]cytosine-1-β-D-arabinofuranoside(CAS DataBase Reference)
• NIST Chemistry Reference: 2',3'-di-O-tert-butyldimethylsilyl-5'-O-cis-[4-(R)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]cytosine-1-β-D-arabinofuranoside(804561-63-5)
• EPA Substance Registry System: 2',3'-di-O-tert-butyldimethylsilyl-5'-O-cis-[4-(R)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]cytosine-1-β-D-arabinofuranoside(804561-63-5)

Safety Data

• Hazardous Substances Data: 804561-63-5(Hazardous Substances Data)

Upstream product

• 87418-91-5 1-[2',3'-di-O-(tert-butyldimethylsilyl)-β-D-arabinofuranosyl]cytosine 
• 805235-83-0 (4R)-(+)-trans-2-(4-nitrophenoxy)-2-oxo-4-(3-chlorophenyl)-1,3,2-dioxaphosphorinane 
• 51699-45-7 (S)-(-)-1-(3'-Chlorophenyl)-1,3-Propanediol 
• 51699-40-2 3-(3-chlorophenyl)-3-hydroxypropionic acid ethyl ester 
• 587-04-2 m-Chlorobenzaldehyde 
• 90362-54-2 1-[2',3',5'-tris-O-(tert-butyldimethylsilyl)-β-D-arabinofuranosyl]cytosine 
• 147-94-4 arabinosyl cytosine 
• 632327-18-5 (R)-(+)-1-(3-chlorophenyl)-1,3-propanediol 
• 804560-96-1 (+/-)-1-(1,3-bistrimethylsilyloxypropyl)-3-chlorobenzene 

Downstream Products

• 693223-04-0 cis-5'-O-[4-(R)-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl]cytosine-1-β-D-arabinofuranoside 

Relevant articles and documents

Design, Synthesis, and Characterization of a Series of Cytochrome P 450 3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver

A new class of phosphate and phosphonate prodrugs, called HepDirect prodrugs, is described that combines properties of rapid liver cleavage with high plasma and tissue stability to achieve increased drug levels in the liver. The prodrugs are substituted c